# Larimar Therapeutics, Inc. (LRMR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LRMR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -169.63M | $ -116.00M | $ 4.07M | $ 78.09M |
| 2024 | $ 0 | $ -84.72M | $ -74.92M | $ 5.12M | $ 171.81M |
| 2023 | $ 0 | $ -39.95M | $ -36.35M | $ 5.55M | $ 81.72M |
| 2022 | $ 0 | $ -39.50M | $ -30.91M | $ 5.41M | $ 110.90M |
| 2021 | $ 0 | $ -60.19M | $ -50.44M | $ 6.00M | $ 64.41M |
| 2020 | $ 0 | $ -54.12M | $ -53.84M | $ 6.52M | $ 89.69M |
| 2019 | $ 0 | $ -23.77M | $ -29.41M | $ 97.0K | $ -694.0K |
| 2018 | $ 0 | $ -81.05M | $ -85.51M | $ 20.64M | $ 93.27M |
| 2017 | $ 0 | $ -70.09M | $ 0 | $ 20.00M | $ 78.22M |
| 2016 | $ 0 | $ -79.63M | $ 0 | $ 3.59M | $ 121.73M |
| 2015 | $ 0 | $ -104.30M | $ -84.45M | $ 6.39M | $ 169.11M |
| 2014 | $ 0 | $ -29.86M | N/A | $ 7.56M | $ 104.44M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.87 |
| Current Ratio | 2.19 |

## Other views

- [Metrics](https://sponda.capital/en/LRMR.md)
- [Charts](https://sponda.capital/en/LRMR/charts.md)
- [Compare](https://sponda.capital/en/LRMR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.